drugset / Trial / NCT02794610

Ocular Penetration of Topical Tacrolimus Eye Drops

NCT02794610

NaSingle-groupOpen-labelTreatment

Summary

Investigators aim to evaluate the ocular penetration of topical tacrolimus 0.03% eye drops. Topical tacrolimus 0.03% will be instilled into the eyes of patients 15 minutes before cataract surgery. Aqueous samples will be collected at the time of cataract surgery and will be subjected to detection of presence and level of tacrolimus.

Timeline

Start
2016-05
Primary completion
2016-06
Completion
2016-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Tacrolimus Small molecule 0.05 % Topical

Indications

No indication recorded.